Showing results (321-330 of 419) with videos related to

Sort By:
Pageof 42
RMD Open|March 1, 2016
Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION studyRieke Alten, Hubert Nüßlein, Mauro Galeazzi, et al.
RMD Open|August 28, 2019
Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatmentMark C Genovese, Désirée van der Heijde, Yong Lin, et al.
Scientific Reports|May 15, 2020
Synovial tissue transcriptomes of long-standing rheumatoid arthritis are dominated by activated macrophages that reflect microbial stimulationBiljana Smiljanovic, Andreas Grützkau, Till Sörensen, et al.
Annals of the Rheumatic Diseases|June 24, 2019
EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseasesLaure Gossec, Joanna Kedra, Hervé Servy, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2019
Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid ArthritisPeter C Taylor, Michael E Weinblatt, Gerd R Burmester, et al.
Stem Cells and Development|November 13, 2009
The human nose harbors a niche of olfactory ectomesenchymal stem cells displaying neurogenic and osteogenic propertiesBruno Delorme, Emmanuel Nivet, Julien Gaillard, et al.
Lancet (London, England)|July 27, 2020
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trialGerd R Burmester, Frank Buttgereit, Corrado Bernasconi, et al.
The Journal of Rheumatology|March 19, 2013
Gene expression of catalytic proteasome subunits and resistance toward proteasome inhibition of B lymphocytes from patients with primary sjogren syndromeLorena Martinez-Gamboa, Karsten Lesemann, Ulrike Kuckelkorn, et al.
Annals of the Rheumatic Diseases|July 9, 2026
A head-to-head comparison of abatacept and adalimumab in adults with early and dual seropositive rheumatoid arthritis plus HLA-DRB1 shared epitope: results from the randomised phase 3 AMPLIFIED trialPaul Emery, Michael E Weinblatt, Vivian P Bykerk, et al.
Clinical and Experimental Rheumatology|March 12, 2016
Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world studyHubert G Nüßlein, Rieke Alten, Mauro Galeazzi, et al.
Pageof 42